Sister chromatid exchanges produced by imipramine and desipramine in mouse bone marrow cells treated in vivo.
Imipramine and desipramine are two widely used tricyclic antidepressants which have shown conflicting results in regard to their in vitro genotoxic evaluation. The aim of this investigation was to determine the capacity of these compounds to induce in vivo sister-chromatid exchanges (SCEs) in mouse bone marrow cells. For each compound, the animals were organized in five groups constituted by five individuals. They were intraperitoneally (ip) administered with the test substances as follows: a negative control group treated with 0.4 ml of distilled water, a positive control group administered with cyclophosphamide (70 mg/kg), three groups treated with imipramine (7, 20 and 60 mg/kg), and three other groups treated with desipramine (2, 20 and 60 mg/kg). The general procedure included the subcutaneous implantation to each mouse of a 5-bromodesoxyuridine tablet (45 mg), and 1 h later, the administration of the chemicals involved. Twenty-one hours after the tablet implantation, the mice received colchicine, and 3 h later their femoral bone marrow was obtained in KCL, fixed, and stained with the Hoechst-Giemsa method. The results showed that both compounds were SCE inducers, starting from the second tested dose. The response of these compounds was dose-dependent, and showed that the highest tested dose increased about four times the SCE control level. The cellular proliferation kinetics was not affected by the chemicals, and the mitotic indexes were slightly diminished with the highest dose. These results indicate an in vivo genotoxic potential for both chemicals, and suggest that it is pertinent to follow their evaluation in other models.
Paniagua-Pérez
R
R
Centro Nacional de Rehabilitación S.S., Escuela Nacional de Ciencias Biológicas, I.P.N. Carpio y Plan de Ayala, Sto Tomas, cp 11340, Mexico D.F., Mexico.
Madrigal-Bujaidar
E
E
Reyes
C S
CS
Pérez
G J
GJ
Velasco
M O
MO
Molina
D
D
D000818:Animals; D000929:Antidepressive Agents, Tricyclic / Q000633:toxicity*; D001853:Bone Marrow / Q000187:drug effects; D003520:Cyclophosphamide / Q000494:pharmacology; D003891:Desipramine / Q000633:toxicity*; D007099:Imipramine / Q000633:toxicity*; D007274:Injections, Intraperitoneal; D008297:Male; D051379:Mice; D009153:Mutagens / Q000494:pharmacology; D012044:Regression Analysis; D012854:Sister Chromatid Exchange / Q000187:drug effects*
D000929:Antidepressive Agents, Tricyclic; D009153:Mutagens; D003520:Cyclophosphamide; D007099:Imipramine; D003891:Desipramine